Friends! In this video, I'm going to do an analysis on Marvel stock, CostCO stock, and CrowdStrike stock.
3 extracted signals · 3 resolved · 0 still active
The Patient InvestorIndependent analyst profile- Source published
- 13 Sept 2025, 21:26 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The analysis focuses on three stocks: CRM, FTNT, and CMG. CRM's revenue growth has peaked, and its P/FCF multiple has decreased, suggesting a potential bearish outlook. FTNT, despite being a cybersecurity play, shows slowing revenue growth and has faced analyst scrutiny, leading to a potential valuation reset. CMG, while having a strong brand, is experiencing a significant slowdown in revenue growth and a decline in its stock price, making it a high-risk, high-reward opportunity. The overall market sentiment suggests caution due to decelerating growth and potentially overvalued multiples in some sectors.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
3 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
The Patient Investor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.


